lactic acid has been researched along with Cardiac Output, Low in 28 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Cardiac Output, Low: A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ranolazine was previously shown to stimulate cardiac glucose oxidation." | 5.29 | Effects of ranolazine on the exercise capacity of rats with chronic heart failure induced by myocardial infarction. ( Aaker, A; Hirai, T; McCormack, JG; Musch, TI, 1996) |
| "We describe a patient with carnitine-acylcarnitine translocase deficiency (MIM 212138), who presented with neonatal generalized seizures, heart failure, and coma." | 3.70 | Carnitine-acylcarnitine translocase deficiency: metabolic consequences of an impaired mitochondrial carnitine cycle. ( Dorland, L; Duran, M; IJlst, L; Muntau, AC; Roscher, AA; Röschinger, W; Wanders, RJ, 2000) |
| "One patient in group T developed low cardiac output syndrome 48 hours after the operation and died after 1 month." | 2.71 | Markers of myocardial ischemia in the evaluation of the effect of left anterior descending coronary artery lesion and collateral circulation on myocardial injury in 1-vessel off-pump coronary bypass surgery. ( Alp, M; Güzelmeriç, F; Kayalar, N; Kirali, K; Mansuroğlu, D; Yakut, C, 2003) |
| "Low cardiac output syndrome is common after paediatric cardiac surgery." | 1.38 | Serum cortisol concentration with exploratory cut-off values do not predict the effects of hydrocortisone administration in children with low cardiac output after cardiac surgery. ( de Jonge, E; Hazekamp, MG; Hogenbirk, K; Roest, AA; van Brempt, R; Verweij, EJ, 2012) |
| "Levosimendan produced an increase in cΔHbD (p < 0." | 1.37 | Acute effects of levosimendan on cerebral and systemic perfusion and oxygenation in newborns: an observational study. ( Bravo, MC; Bravo, Mdel C; Cabañas, F; López, P; Pellicer, A; Pérez-Fernández, E; Pérez-Rodríguez, J; Quero, J, 2011) |
| "Levosimendan is a calcium-sensitizing agent with effective inotropic properties." | 1.35 | First experiences with intraoperative Levosimendan in pediatric cardiac surgery. ( Boethig, D; Goerler, H; Huber, D; Osthaus, WA; Sasse, M; Sümpelmann, R; Winterhalter, M, 2009) |
| "Free carnitine levels were progressively decreased at 3 w (74% of control values) and at 6 w (57% of control values)." | 1.29 | Cardiac energy metabolism at several stages of adriamycin-induced heart failure in rats. ( Ishii, Y; Kawasaki, N; Lee, JD; Shimizu, H; Ueda, T, 1996) |
| "Ranolazine was previously shown to stimulate cardiac glucose oxidation." | 1.29 | Effects of ranolazine on the exercise capacity of rats with chronic heart failure induced by myocardial infarction. ( Aaker, A; Hirai, T; McCormack, JG; Musch, TI, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.57) | 18.7374 |
| 1990's | 10 (35.71) | 18.2507 |
| 2000's | 11 (39.29) | 29.6817 |
| 2010's | 5 (17.86) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Aslan, N | 1 |
| Yıldızdaş, D | 1 |
| Göçen, U | 1 |
| Erdem, S | 1 |
| Demir, F | 1 |
| Yontem, A | 1 |
| Horoz, ÖÖ | 1 |
| Sertdemir, Y | 1 |
| Park, SJ | 2 |
| Kim, SP | 1 |
| Kim, JB | 2 |
| Jung, SH | 2 |
| Choo, SJ | 2 |
| Chung, CH | 2 |
| Lee, JW | 2 |
| Osthaus, WA | 1 |
| Boethig, D | 1 |
| Winterhalter, M | 1 |
| Huber, D | 1 |
| Goerler, H | 1 |
| Sasse, M | 1 |
| Sümpelmann, R | 1 |
| Bravo, MC | 1 |
| Bravo, Mdel C | 1 |
| López, P | 1 |
| Cabañas, F | 1 |
| Pérez-Rodríguez, J | 1 |
| Pérez-Fernández, E | 1 |
| Quero, J | 1 |
| Pellicer, A | 1 |
| Onorati, F | 1 |
| Santini, F | 1 |
| Amoncelli, E | 1 |
| Campanella, F | 1 |
| Chiominto, B | 1 |
| Faggian, G | 1 |
| Mazzucco, A | 1 |
| Verweij, EJ | 1 |
| Hogenbirk, K | 1 |
| Roest, AA | 1 |
| van Brempt, R | 1 |
| Hazekamp, MG | 1 |
| de Jonge, E | 1 |
| Myers, J | 1 |
| Wagner, D | 1 |
| Schertler, T | 1 |
| Beer, M | 1 |
| Luchinger, R | 1 |
| Klein, M | 1 |
| Rickli, H | 1 |
| Muller, P | 1 |
| Mayer, K | 1 |
| Schwitter, J | 1 |
| Dubach, P | 1 |
| Hoffman, TM | 1 |
| Wernovsky, G | 1 |
| Atz, AM | 1 |
| Kulik, TJ | 1 |
| Nelson, DP | 1 |
| Chang, AC | 1 |
| Bailey, JM | 1 |
| Akbary, A | 1 |
| Kocsis, JF | 1 |
| Kaczmarek, R | 1 |
| Spray, TL | 1 |
| Wessel, DL | 1 |
| Kirali, K | 1 |
| Mansuroğlu, D | 1 |
| Kayalar, N | 1 |
| Güzelmeriç, F | 1 |
| Alp, M | 1 |
| Yakut, C | 1 |
| Middlekauff, HR | 1 |
| Chiu, J | 1 |
| Hamilton, MA | 1 |
| Fonarow, GC | 1 |
| Maclellan, WR | 1 |
| Hage, A | 1 |
| Moriguchi, J | 1 |
| Patel, J | 1 |
| Zakynthinos, S | 1 |
| Routsi, C | 1 |
| Vassilakopoulos, T | 1 |
| Kaltsas, P | 1 |
| Zakynthinos, E | 1 |
| Kazi, D | 1 |
| Roussos, C | 1 |
| Richard, C | 1 |
| Teboul, JL | 1 |
| Doutreleau, S | 1 |
| Mettauer, B | 1 |
| Piquard, F | 1 |
| Schaefer, A | 1 |
| Lonsdorfer, E | 1 |
| Richard, R | 1 |
| Geny, B | 1 |
| Ruokonen, E | 1 |
| Takala, J | 1 |
| Kari, A | 1 |
| Wilson, JR | 1 |
| Mancini, DM | 1 |
| Dunkman, WB | 1 |
| Reading, JL | 1 |
| Goodman, JM | 1 |
| Plyley, MJ | 1 |
| Floras, JS | 1 |
| Liu, PP | 1 |
| McLaughlin, PR | 1 |
| Shephard, RJ | 1 |
| Kawasaki, N | 1 |
| Lee, JD | 1 |
| Shimizu, H | 1 |
| Ishii, Y | 1 |
| Ueda, T | 1 |
| Aaker, A | 1 |
| McCormack, JG | 1 |
| Hirai, T | 1 |
| Musch, TI | 1 |
| Wasserman, K | 2 |
| Röschinger, W | 1 |
| Muntau, AC | 1 |
| Duran, M | 1 |
| Dorland, L | 1 |
| IJlst, L | 1 |
| Wanders, RJ | 1 |
| Roscher, AA | 1 |
| Rao, V | 1 |
| Ivanov, J | 1 |
| Weisel, RD | 1 |
| Cohen, G | 1 |
| Borger, MA | 1 |
| Mickle, DA | 1 |
| Rackow, EC | 1 |
| O'Neil, P | 1 |
| Astiz, ME | 1 |
| Carpati, CM | 1 |
| Pawelczyk, JA | 1 |
| Hanel, B | 1 |
| Pawelczyk, RA | 1 |
| Warberg, J | 1 |
| Secher, NH | 1 |
| Cilley, RE | 1 |
| Scharenberg, AM | 1 |
| Bongiorno, PF | 1 |
| Guire, KE | 1 |
| Bartlett, RH | 1 |
| Cohen-Solal, A | 1 |
| Benessiano, J | 1 |
| Himbert, D | 1 |
| Paillole, C | 1 |
| Gourgon, R | 1 |
| Cryer, HG | 1 |
| Mavroudis, C | 1 |
| Yu, J | 1 |
| Roberts, AM | 1 |
| Cué, JI | 1 |
| Richardson, JD | 1 |
| Polk, HC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Perioperative Levosimendan Administration in Neonates With Transposition of the Great Arteries: Randomized Controlled Trial[NCT01120106] | Phase 2 | 63 participants (Actual) | Interventional | 2009-01-31 | Completed | ||
| Phase I Study of Two Inodilators in Neonates Undergoing Cardiovascular Surgery[NCT01576094] | Phase 1/Phase 2 | 20 participants (Actual) | Interventional | 2009-11-30 | Completed | ||
| STeroids to REduce Systemic Inflammation After Infant Heart Surgery (STRESS)[NCT03229538] | Phase 3 | 1,263 participants (Actual) | Interventional | 2017-10-18 | Completed | ||
| Phase 2 Prospective, Randomized, Double-Blind Pilot Study on Cardiac Output Following Corrective Open Heart Surgery in Children Less Than One Year: Use of Levosimendan Versus Milrinone.[NCT00549107] | Phase 2 | 40 participants (Anticipated) | Interventional | 2007-09-30 | Recruiting | ||
| Preoperative Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass[NCT00934843] | 77 participants (Actual) | Interventional | 2007-03-31 | Completed | |||
| Use of the Cardioprotectant Dexrazoxane During Congenital Heart Surgery: Proposal for Pilot Investigation[NCT02519335] | Phase 1 | 12 participants (Actual) | Interventional | 2014-09-30 | Terminated (stopped due to PI no longer at this facility) | ||
| 2- Inhaled Milrinone Prevents the Increase in Pulmonary Artery Pressure After CPB[NCT00819377] | Phase 2 | 124 participants (Anticipated) | Interventional | 2009-02-28 | Completed | ||
| Use of the Cardioprotectant Dexrazoxane During Congenital Heart Surgery[NCT04997291] | Phase 1 | 12 participants (Anticipated) | Interventional | 2021-04-09 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Calculated as discharge date minus surgery date. (NCT03229538)
Timeframe: Until hospital discharge, up to 4 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Methylprednisolone Arm | 18 |
| Placebo Arm | 29 |
(NCT03229538)
Timeframe: Until hospital discharge, up to 4 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Methylprednisolone Arm | 237 |
| Placebo Arm | 264 |
The 7 highest global ranking categories range from 91 (postoperative length of hospital stay > 90 days) to 97 (operative mortality). (NCT03229538)
Timeframe: Until hospital discharge, up to 4 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Methylprednisolone Arm | 103 |
| Placebo Arm | 122 |
(NCT03229538)
Timeframe: up to 30 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Methylprednisolone Arm | 12 |
| Placebo Arm | 17 |
(NCT03229538)
Timeframe: Until hospital discharge, up to 4 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Methylprednisolone Arm | 31 |
| Placebo Arm | 24 |
"Based upon the STS-CHSD registry defined cardiac dysfunction resulting in low cardiac output complication variable." (NCT03229538)
Timeframe: Until hospital discharge, up to 4 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Methylprednisolone Arm | 31 |
| Placebo Arm | 37 |
(NCT03229538)
Timeframe: Until hospital discharge, up to 4 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Methylprednisolone Arm | 41 |
| Placebo Arm | 51 |
The inotropic score was calculated by the equation using drug dosages in micrograms/kg/min, (dopamine+dobutamine) + (milrinonex10) + (epinephrinex100) and recorded hourly upon arrival to the ICUthrough 36 hours postoperatively. The highest score during this timeframe was recorded. This score converts dosages of commonly used inotropic medications into a score. The higher the score the more inotropic medications required. The minimum score would be zero indicating no inotropic medications were used. There is no maximum score. (NCT00934843)
Timeframe: over the first 36 hours after surgery
| Intervention | Scores on a scale (Mean) |
|---|---|
| MP Single Dose | 14.4 |
| MP Two Dose | 15.0 |
Number of participants who died of any cause between 36 hours and 30 days following cardiac surgery (NCT00934843)
Timeframe: at 36 hours and 30 days
| Intervention | participants (Number) |
|---|---|
| MP Single Dose | 1 |
| MP Two Dose | 0 |
The presence of low cardiac output syndrome (LCOS) was defined by the same definition used in the PRIMACORP study (Hoffman TM.et.al. Circulation 2003 107:996-1002). Specifically, if there were clinical signs and symptoms of low cardiac output (e.g., tachycardia, oliguria, cold extremities, cardiac arrest, etc.) which required one or more of the following interventions: mechanical circulatory support, the escalation of existing pharmacological circulatory support to >100% over baseline, or the initiation of new pharmacological circulatory support. (NCT00934843)
Timeframe: 36 hours
| Intervention | participants (Number) |
|---|---|
| MP Single Dose | 17 |
| MP Two Dose | 15 |
Total urine output in mL over the first 36 hours after cardiac surgery (NCT00934843)
Timeframe: over 36 hours
| Intervention | mL (Mean) |
|---|---|
| MP Single Dose | 498 |
| MP Two Dose | 453 |
Total amount of all fluids in and out during the first 36 hours postoperatively in mL. (NCT00934843)
Timeframe: over 36 hours
| Intervention | mL (Mean) | |
|---|---|---|
| Total Fluid in at 36 hr | Total Fluid out at 36 hr | |
| MP Single Dose | 575 | 600 |
| MP Two Dose | 586 | 558 |
6 trials available for lactic acid and Cardiac Output, Low
| Article | Year |
|---|---|
How should I wean my next intra-aortic balloon pump? Differences between progressive volume weaning and rate weaning.
Topics: Aged; Arterial Pressure; Biomarkers; Cardiac Output; Cardiac Output, Low; Central Venous Pressure; F | 2013 |
Effects of exercise training on left ventricular volumes and function in patients with nonischemic cardiomyopathy: application of magnetic resonance myocardial tagging.
Topics: Cardiac Output, Low; Exercise Therapy; Female; Humans; Lactic Acid; Magnetic Resonance Imaging; Male | 2002 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determin | 2003 |
Markers of myocardial ischemia in the evaluation of the effect of left anterior descending coronary artery lesion and collateral circulation on myocardial injury in 1-vessel off-pump coronary bypass surgery.
Topics: Adult; Aged; Biomarkers; Cardiac Output, Low; Collateral Circulation; Coronary Artery Bypass; Corona | 2003 |
Muscle mechanoreceptor sensitivity in heart failure.
Topics: Arm; Cardiac Output, Low; Constriction; Dichloroacetic Acid; Double-Blind Method; Exercise; Female; | 2004 |
Regional blood flow and oxygen transport in patients with the low cardiac output syndrome after cardiac surgery.
Topics: Body Temperature; Calorimetry, Indirect; Cardiac Output, Low; Coronary Artery Bypass; Dobutamine; Dr | 1993 |
22 other studies available for lactic acid and Cardiac Output, Low
| Article | Year |
|---|---|
[Low cardiac output syndrome score to evaluate postoperative cardiac surgery patients in a pediatric intensive care unit].
Topics: Aorta; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Child, Preschool; C | 2020 |
Blood lactate level during extracorporeal life support as a surrogate marker for survival.
Topics: Adult; Aged; Area Under Curve; Biomarkers; Cardiac Output, Low; Cardiac Surgical Procedures; Chi-Squ | 2014 |
First experiences with intraoperative Levosimendan in pediatric cardiac surgery.
Topics: Cardiac Output; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Heart; Heart D | 2009 |
Acute effects of levosimendan on cerebral and systemic perfusion and oxygenation in newborns: an observational study.
Topics: Blood Pressure; Cardiac Output, Low; Cardiotonic Agents; Cerebrovascular Circulation; Heart Defects, | 2011 |
Serum cortisol concentration with exploratory cut-off values do not predict the effects of hydrocortisone administration in children with low cardiac output after cardiac surgery.
Topics: Adrenal Insufficiency; Age Factors; Biomarkers; Blood Pressure; Cardiac Output, Low; Cardiac Surgica | 2012 |
Outcomes of extracorporeal life support for low cardiac output syndrome after major cardiac surgery.
Topics: Adult; Aged; Anticoagulants; Area Under Curve; Benzamidines; Biomarkers; Cardiac Output, Low; Cardia | 2014 |
Differential cardiovascular responses during weaning failure: effects on tissue oxygenation and lactate.
Topics: Aged; Aged, 80 and over; Cardiac Output; Cardiac Output, Low; Case-Control Studies; Female; Heart Fa | 2005 |
Weaning failure from cardiovascular origin.
Topics: Cardiac Output, Low; Heart Failure; Humans; Lactic Acid; Oxygen; Pulmonary Disease, Chronic Obstruct | 2005 |
Chronic but not acute oral L-arginine supplementation delays the ventilatory threshold during exercise in heart failure patients.
Topics: Anaerobic Threshold; Arginine; Carbon Dioxide; Cardiac Output, Low; Drug Administration Schedule; Ex | 2005 |
Exertional fatigue due to skeletal muscle dysfunction in patients with heart failure.
Topics: Adult; Arteries; Cardiac Output, Low; Fatigue; Femoral Vein; Humans; Lactates; Lactic Acid; Leg; Mal | 1993 |
Vascular conductance and aerobic power in sedentary and active subjects and heart failure patients.
Topics: Adult; Aerobiosis; Blood Pressure; Cardiac Output; Cardiac Output, Low; Exercise Test; Fatigue; Fema | 1993 |
Cardiac energy metabolism at several stages of adriamycin-induced heart failure in rats.
Topics: Adenosine Triphosphate; Alanine; Animals; Cardiac Output, Low; Carnitine; Chromatography, High Press | 1996 |
Effects of ranolazine on the exercise capacity of rats with chronic heart failure induced by myocardial infarction.
Topics: Acetanilides; Animals; Blood Glucose; Cardiac Output, Low; Enzyme Inhibitors; Female; Glycogen; Lact | 1996 |
Critical capillary PO2 and the role of lactate production in oxyhemoglobin dissociation during exercise.
Topics: Acidosis, Lactic; Adult; Blood Gas Analysis; Buffers; Capillaries; Cardiac Output, Low; Exercise; Fe | 1999 |
Carnitine-acylcarnitine translocase deficiency: metabolic consequences of an impaired mitochondrial carnitine cycle.
Topics: Ammonia; Cardiac Output, Low; Carnitine; Carnitine Acyltransferases; Cells, Cultured; Coma; Consangu | 2000 |
Lactate release during reperfusion predicts low cardiac output syndrome after coronary bypass surgery.
Topics: Aged; Cardiac Output, Low; Coronary Artery Bypass; Creatine Kinase; Creatine Kinase, MB Form; Female | 2001 |
Sublingual capnometry and indexes of tissue perfusion in patients with circulatory failure.
Topics: APACHE; Blood Circulation; Capnography; Carbon Dioxide; Cardiac Output, Low; Gastric Mucosa; Hemodyn | 2001 |
Leg vasoconstriction during dynamic exercise with reduced cardiac output.
Topics: Adult; Blood Gas Analysis; Cardiac Output, Low; Catecholamines; Exercise; Female; Heart Rate; Humans | 1992 |
Low oxygen delivery produced by anemia, hypoxia, and low cardiac output.
Topics: Anemia; Animals; Cardiac Output, Low; Dogs; Hypoxia; Lactates; Lactic Acid; Oxygen Consumption; Ther | 1991 |
Ventilatory threshold during exercise in patients with mild to moderate chronic heart failure: determination, relation with lactate threshold and reproducibility.
Topics: Adult; Aged; Breath Tests; Carbon Dioxide; Cardiac Output, Low; Exercise Test; Humans; Lactates; Lac | 1991 |
Shock, transfusion, and pneumonectomy. Death is due to right heart failure and increased pulmonary vascular resistance.
Topics: Animals; Blood Pressure; Blood Transfusion; Cardiac Output; Cardiac Output, Low; Heart; Lactates; La | 1990 |
The peripheral circulation and lactic acid metabolism in heart, or cardiovascular, failure.
Topics: Blood Circulation; Blood Vessels; Cardiac Output; Cardiac Output, Low; Cardiovascular System; Glycog | 1989 |